CELLJUVANT CELL-BASED ADJUVANT TECHNOLOGY

Live / Applied — Non-final action mailed (as of 01 Sept 2026)

Now

Refused for now — an office action was mailed 01 Sept 2026.

A response is due by 01 Dec 2026; with no response the application is abandoned.

What this means for you

Not registered yet, but its 21 Apr 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
99777553
Mark type
Slogan / phrase
Filed
21 Apr 2026
Attorney of record
Nancy Sabarra

Goods and services

  • Class 005 — Pharmaceuticals: Vaccines; vaccines for human use; flu vaccines
  • Class 042 — Scientific and technological services: Providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development; Providing information about pharmaceutical research and development
  • Class 044 — Medical, beauty and agricultural services: Medical information; pharmaceutical information, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical information services in the field of pharmaceuticals for preventing and treating viruses and respiratory disorders, including vaccines and pharmaceutical therapeutics

Owner

Prosecution history

  • 01 Sept 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 01 Sept 2026 — NON-FINAL ACTION E-MAILED
  • 01 Sept 2026 — NON-FINAL ACTION WRITTEN
  • 26 Aug 2026 — ASSIGNED TO EXAMINER
  • 25 Aug 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
  • 21 Apr 2026 — APPLICATION FILING RECEIPT MAILED
  • 21 Apr 2026 — NEW APPLICATION ENTERED

View this trademark record on Rightsy